# Development of NIC5-15 in the Treatment of Alzheimer's Disease

> **NCT00470418** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 15 (actual)

## Conditions studied

- Alzheimer Disease
- Dementia

## Interventions

- **DRUG:** NIC5-15
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00470418
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-08
- **Final completion:** 2010-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470418, "Development of NIC5-15 in the Treatment of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00470418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*